ALS (Amyotrophic Lateral Sclerosis)

What We Know About ALS

The clinical course is heterogeneous. Some patients progress over years; others progress more rapidly. Symptom domains include motor function loss, dysphagia, respiratory decline, and — in a subset of patients — cognitive change.

How TX CUP Addresses ALS

Our Experience Treating ALS Under CUP

Typical observations from CURT physicians evaluating ALS patients under the Texas program include considerations around:

• Coordination with the patient’s primary neurologist or ALS clinic team
• Drug-interaction screening against riluzole, edaravone, or other disease-specific therapies
• Dosage-form considerations given dysphagia in advanced disease
• Caregiver involvement in evaluation logistics

What to Expect at the Evaluation

A CURT physician evaluating an ALS patient typically reviews:

• The diagnostic workup confirming ALS (EMG, neurology consult notes, exclusion of mimics)
• Current functional status (ALSFRS-R or equivalent if available)
• Current symptom-management regimen
• Caregiver and home-care context if relevant to product administration

The evaluation may be conducted by telehealth with a caregiver present at the patient’s discretion.

Common Patient Questions About ALS and the TX CUP

Last Verified

Next Step

Bookings route through miracleleaftx.com.